查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1582704

全球非侵入性產前檢測 (NIPT) 市場：產業分析、規模、佔有率、成長、趨勢和預測 (2024-2033)

Non-invasive Prenatal Testing (NIPT) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 136 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告調查了全球無創產前檢測（NIPT）市場，並提供了市場定義和概述、市場促進和阻礙因素、各種趨勢、市場機會、課題、市場規模趨勢，它總結了預測，詳細分析了各種細分市場/地區/主要國家、競爭環境、主要公司概況等。

主要的洞察

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義
  • 市場分類

第三章全球非侵入性產前檢測市場分析情境

  • 價格分析
  • 市場/預測
    • 市場規模/年成長率
  • 市場概覽

第 4 章市場動態

  • 宏觀經濟因素
  • 促進因素
  • 阻礙因素
  • 成長機會
  • 趨勢
  • 監管場景
  • 兌換場景
  • 產物比較矩陣
  • 陽性預測值比較

第五章全球無創產前檢測市場分析與預測：通過測試

  • BPS 分析
  • 年成長預測
  • 市場規模預測
    • 第 1 組檢查
    • 第 2 組檢查
    • 第 3 組檢查
  • 市場吸引力

第六章全球非侵入性產前檢測市場分析與預測：依最終用戶劃分

  • BPS 分析
  • 年成長預測
  • 市場規模預測
    • 醫院
    • 診斷實驗室
    • 婦產中心
  • 市場吸引力

第七章全球非侵入性產前檢測市場分析及預測：分地區

  • BPS 分析
  • 年成長預測
  • 市場規模預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 市場吸引力

第八章北美非侵入性產前檢測市場分析及預測

  • 市場規模預測：通過測試
  • 市場規模預測：依最終用戶劃分
  • 市場規模預測：依國家劃分
  • 市場吸引力分析
  • 顯著趨勢

第九章拉丁美洲無創產前檢測市場分析與預測

  • 市場規模預測：通過測試
  • 市場規模預測：依最終用戶劃分
  • 市場規模預測：依國家劃分
  • 市場吸引力分析
  • 顯著趨勢

第十章歐洲無創產前檢測市場分析與預測

  • 市場規模預測：通過測試
  • 市場規模預測：依最終用戶劃分
  • 市場規模預測：依國家劃分
  • 市場吸引力分析
  • 顯著趨勢

第11章亞太地區非侵入性產前檢測市場分析及預測

  • 市場規模預測：通過測試
  • 市場規模預測：依最終用戶劃分
  • 市場規模預測：依國家劃分
  • 市場吸引力分析
  • 顯著趨勢

第十二章中東及非洲非侵入性產前檢測市場分析及預測

  • 市場規模預測：通過測試
  • 市場規模預測：依最終用戶劃分
  • 市場規模預測：依國家劃分
  • 市場吸引力分析
  • 顯著趨勢

第十三章競爭態勢

  • 競爭對手儀表板
  • 公司簡介
    • Ariosa Diagnostics, Inc.
    • Berry Genomics Co. Ltd.
    • BGI Diagnostics
    • Illumina, Inc.
    • LifeCodexx AG
    • Natera, Inc.
    • Sequenom Laboratories
    • Quest Diagnostics, Inc.

第 14 章假設/縮寫

第十五章研究方法

簡介目錄
Product Code: PMRREP11218

Persistence Market Research has recently released a comprehensive report on the global Non-invasive Prenatal Testing (NIPT) market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • NIPT Market Size (2024E): USD 7.1 Bn
  • Projected Market Value (2031F): USD 16.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 12.5%

NIPT Market - Report Scope:

Non-invasive prenatal testing (NIPT) is a revolutionary technology used in prenatal screening for detecting chromosomal abnormalities in a fetus. Unlike invasive testing methods, NIPT uses cell-free fetal DNA (cffDNA) from the mother's blood, providing accurate results with minimal risk. This technology is essential for expectant mothers and healthcare providers, offering early insights into genetic abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. The NIPT market caters to diagnostic laboratories, hospitals, clinics, and various healthcare institutions, with growth fueled by increasing awareness of genetic disorders, advances in testing technology, and a rising preference for early non-invasive diagnostics.

Market Growth Drivers:

The global NIPT market is driven by several key factors. Increasing awareness of genetic disorders, especially among expectant parents, is a significant growth catalyst. Advances in DNA sequencing technology and the availability of high-accuracy screening are increasing the adoption of NIPT. Additionally, the demand for safe, non-invasive prenatal screening continues to grow as more healthcare providers advocate for early detection of chromosomal abnormalities. The rising maternal age and associated risk of genetic disorders also contribute to the increased utilization of NIPT services, while the advancements in AI and bioinformatics improve the precision and reliability of testing.

Market Restraints:

While the NIPT market shows promising growth, it faces challenges such as high test costs and limited insurance coverage in certain regions, which can impact accessibility for a broader population. Regulatory constraints in specific countries and ethical concerns regarding genetic testing also limit market expansion. Moreover, false-positive and false-negative results, though rare, may raise concerns regarding test accuracy. Addressing these challenges requires industry players to focus on cost-effective testing solutions, raise awareness of the safety and efficacy of NIPT, and work closely with policymakers to establish clear regulatory guidelines for market entry.

Market Opportunities:

The NIPT market presents notable opportunities fueled by ongoing research and technological advancements. Increasing R&D investments, especially in high-sensitivity and specific testing methods, offer potential for new product development and market expansion. The market is also likely to benefit from greater integration of NIPT with genetic counseling services, providing a holistic approach to prenatal care. Expanding NIPT into emerging markets, where demand is growing for modern healthcare solutions, also presents a significant growth area. Strategic partnerships with insurance companies, hospitals, and research institutions can further enhance market penetration and create new revenue streams.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global NIPT market?
  • Which regions are witnessing the fastest adoption of NIPT solutions?
  • How do technological advancements influence the competitive landscape of the NIPT market?
  • Who are the leading players in the NIPT market, and what are their key strategies?
  • What are the emerging trends and future prospects in the global NIPT market?

Competitive Intelligence and Business Strategy:

Leading players in the global NIPT market, including Illumina Inc., Natera Inc., and Roche Diagnostics, focus on continuous innovation and strategic partnerships to maintain a competitive edge. These companies invest heavily in R&D to enhance the accuracy and reduce the cost of NIPT solutions. Strategic collaborations with healthcare providers and institutions strengthen market accessibility and foster product adoption. Emphasis on clinical trials, regulatory approvals, and sustainable marketing strategies also contributes to market growth and builds consumer confidence in the safety and efficacy of NIPT.

Key Companies Profiled:

  • Ariosa Diagnostics, Inc.
  • Berry Genomics Co. Ltd.
  • BGI Diagnostics
  • Illumina, Inc.
  • LifeCodexx AG
  • Natera, Inc.
  • Sequenom Laboratories
  • Quest Diagnostics, Inc.
  • Others

Non-invasive Prenatal Testing (NIPT) Market Industry Segmentation:

By Test Type

  • Panel 1 Tests
  • Panel 2 Tests
  • Panel 3 Tests

By End User

  • Hospitals
  • Diagnostic Centers
  • Maternity Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Non-Invasive Prenatal Testing Market Analysis Scenario

  • 3.1. Pricing Analysis
    • 3.1.1. Pricing Assumptions
    • 3.1.2. Price Projections Per Region
  • 3.2. Market Size (US$ Mn) and Forecast
    • 3.2.1. Market Size and Y-o-Y Growth
    • 3.2.2. Absolute $ Opportunity
  • 3.3. Market Overview
    • 3.3.1. Testing Decision Flow Chart

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Growth Opportunities
  • 4.5. Trends
  • 4.6. Regulatory Scenario
  • 4.7. Reimbursement Scenario
  • 4.8. Product Comparison Matrix
  • 4.9. Positive Predictive Value (PPV) Comparison

5. Global Non-Invasive Prenatal Testing Market Analysis and Forecasts, By Test

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Test Type
  • 5.3. Y-o-Y Growth Projections By Test Type
  • 5.4. Market Value Forecast By Test, 2024-2033
    • 5.4.1. Panel 1 Test
    • 5.4.2. Panel 2 Test
    • 5.4.3. Panel 3 Test
  • 5.5. Market Attractiveness By Test

6. Global Non-Invasive Prenatal Testing Market Analysis and Forecasts, By End User

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By End User
  • 6.3. Y-o-Y Growth Projections By End User
  • 6.4. Market Value Forecast By End User, 2024-2033
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Laboratories
    • 6.4.3. Maternity Centers
  • 6.5. Market Attractiveness By End User

7. Global Non-Invasive Prenatal Testing Market Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. Asia Pacific
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness By Region

8. North America Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
  • 8.2. Market Value Forecast By Test, 2024-2033
    • 8.2.1. Panel 1 Test
    • 8.2.2. Panel 2 Test
    • 8.2.3. Panel 3 Test
  • 8.3. Market Value Forecast By End User, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Maternity Centers
  • 8.4. Market Value Forecast By Country, 2024-2033
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Test
    • 8.5.2. By End User
    • 8.5.3. By Country
  • 8.6. Prominent Trends

9. Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Value Forecast By Test, 2024-2033
    • 9.2.1. Panel 1 Test
    • 9.2.2. Panel 2 Test
    • 9.2.3. Panel 3 Test
  • 9.3. Market Value Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Maternity Centers
  • 9.4. Market Value Forecast By Country, 2024-2033
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Test
    • 9.5.2. By End User
    • 9.5.3. By Country
  • 9.6. Prominent Trends

10. Europe Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 10.1.Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2.Market Value Forecast By Test, 2024-2033
    • 10.2.1. Panel 1 Test
    • 10.2.2. Panel 2 Test
    • 10.2.3. Panel 3 Test
  • 10.3.Market Value Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Maternity Centers
  • 10.4.Market Value Forecast By Country, 2024-2033
    • 10.4.1. UK
    • 10.4.2. France
    • 10.4.3. Germany
    • 10.4.4. Spain
    • 10.4.5. Russia
    • 10.4.6. Italy
    • 10.4.7. Rest of Europe
  • 10.5.Market Attractiveness Analysis
    • 10.5.1. By Test
    • 10.5.2. By End User
    • 10.5.3. By Country
  • 10.6. Prominent Trends

11. Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2.Market Value Forecast By Test, 2024-2033
    • 11.2.1. Panel 1 Test
    • 11.2.2. Panel 2 Test
    • 11.2.3. Panel 3 Test
  • 11.3.Market Value Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Diagnostic Laboratories
    • 11.3.3. Maternity Centers
  • 11.4.Market Value Forecast By Country, 2024-2033
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. ASEAN
    • 11.4.6. Rest of APAC
  • 11.5.Market Attractiveness Analysis
    • 11.5.1. By Test
    • 11.5.2. By End User
    • 11.5.3. By Country
  • 11.6. Prominent Trends

12. Middle East and Africa Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2.Market Value Forecast By Test, 2024-2033
    • 12.2.1. Panel 1 Test
    • 12.2.2. Panel 2 Test
    • 12.2.3. Panel 3 Test
  • 12.3.Market Value Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Diagnostic Laboratories
    • 12.3.3. Maternity Centers
  • 12.4.Market Value Forecast By Country, 2024-2033
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of MEA
  • 12.5.Market Attractiveness Analysis
    • 12.5.1. By Test
    • 12.5.2. By End User
    • 12.5.3. By Country
  • 12.6. Prominent Trends

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. Ariosa Diagnostics, Inc.
    • 13.2.2. Berry Genomics Co. Ltd.
    • 13.2.3. BGI Diagnostics
    • 13.2.4. Illumina, Inc.
    • 13.2.5. LifeCodexx AG
    • 13.2.6. Natera, Inc.
    • 13.2.7. Sequenom Laboratories
    • 13.2.8. Quest Diagnostics, Inc.

14. Assumptions and Acronyms Used

15. Research Methodology